Allen Mooney & Barnes Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
130,036
-11,716
-8% -$945K 1.55% 27
2026
Q1
$12.3M Buy
141,752
+2,721
+2% +$261K 1.77% 29
2025
Q4
$13.4M Buy
139,031
+1,083
+0.8% +$105K 2.01% 23
2025
Q3
$13.1M Buy
137,948
+2,136
+2% +$196K 2.05% 22
2025
Q2
$11.8M Buy
135,812
+1,504
+1% +$128K 1.94% 24
2025
Q1
$12.1M Buy
134,308
+6,360
+5% +$569K 1.96% 20
2024
Q4
$10.2M Buy
127,948
+8,629
+7% +$747K 1.72% 24
2024
Q3
$10.7M Sell
119,319
-649
-0.5% -$54.6K 1.83% 23
2024
Q2
$9.44M Buy
119,968
+6,189
+5% +$507K 1.69% 24
2024
Q1
$9.35M Buy
113,779
+3,472
+3% +$296K 1.79% 24
2023
Q4
$9.09M Buy
110,307
+106,701
+2,959% +$8.13M 1.73% 26
2023
Q3
$283K Buy
3,606
+3
+0.1% +$251 0.06% 121
2023
Q2
$317K Buy
+3,603
New +$310K 0.07% 113
2022
Q2
Sell
-2,424
Closed -$269K 144
2022
Q1
$269K Buy
+2,424
New +$256K 0.06% 129

Other funds holding MDT

Allen Mooney & Barnes Investment Advisors's MDT Position: Q2 2026 in Review

Allen Mooney & Barnes Investment Advisors reduced its Medtronic (MDT) stake by 8.3% in Q2 2026, selling an estimated $945K and leaving 130,036 shares worth $10.2M. The position accounts for 1.55% of the portfolio, ranked #27.

Allen Mooney & Barnes Investment Advisors first reported a position in MDT in Q1 2022 and has held it in 14 quarters since. The position peaked at $13.4M in Q4 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Allen Mooney & Barnes Investment Advisors held 130,036 shares of Medtronic worth $10.2M as of Q2 2026.
  • Allen Mooney & Barnes Investment Advisors sold 11,716 Medtronic shares in Q2 2026, an estimated $945K.
  • Medtronic made up 1.55% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #27 holding.
  • Allen Mooney & Barnes Investment Advisors first reported a position in Medtronic in Q1 2022 and has held it in 14 quarters since.
  • Allen Mooney & Barnes Investment Advisors's Medtronic position peaked at $13.4M in Q4 2025.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.